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Programmed cell death (apoptosis) has an important role in the maintenance of tissue 
homeostasis as well as the progression and ultimate resolution of inflammation. 
During apoptosis, the cell undergoes morphological and biochemical changes [e.g., 
phosphatidylserine (PtdSer) exposure, caspase activation, changes in mitochondrial 
membrane potential and DNA cleavage] that act to shut down cellular function and mark 
the cell for phagocytic clearance. Tissue phagocytes bind and internalize apoptotic cells, 
bodies, and vesicles, providing a mechanism for the safe disposal of apoptotic material. 
Phagocytic removal of apoptotic cells before they undergo secondary necrosis reduces 
the potential for bystander damage to adjacent tissue and importantly initiates signaling 
pathways within the phagocytic cell that act to dampen inflammation. In a pathological 
context, excessive apoptosis or failure to clear apoptotic material results in secondary 
necrosis with the release of pro-inflammatory intracellular contents. In this review, we 
consider some of the mechanisms by which phagocytosis of apoptotic cells can be 
controlled. We suggest that matching apoptotic cell load with the capacity for apoptotic 
cell clearance within tissues may be important for therapeutic strategies that target the 
apoptotic process for treatment of inflammatory disease.
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APOPTOTIC CELL CLEARANCE IN HOMEOSTASIS AND 
INFLAMMATION
The controlled elimination of cells during development allows the remodeling of tissues and 
organs to purpose them for specialized functions (reviewed in Elliott and Ravichandran, 2010). 
In fully formed adult organisms, it is estimated that approximately 50 million cells are deleted 
by apoptosis every hour, providing a mechanism for homeostatic self-renewal (Nagata, 2018). 
Apoptosis also has an important role in the responses to injury or infection, controlling the 
numbers of inflammatory cells present at inflamed sites (Poon et al., 2014), shaping the repertoire 
of effector lymphocyte populations (Albert, 2004), and determining the capacity for repair and 
regeneration of tissue following injury (Bosurgi et al., 2017). Importantly, the consequences of cell 
death are ultimately defined by the mechanism(s) by which apoptotic cells (AC) are removed from 
tissues (Savill et al., 2002). Thus, the molecular pathways involved in recognition and subsequent 
phagocytosis of AC will determine whether apoptotic cell clearance is immunologically “silent” or 
even anti-inflammatory. By implication, breakdown or failure of normal AC removal mechanisms 
will increase the tissue load of AC and secondarily necrotic cells and has the potential to drive 
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the aberrant tissue repair responses and failure to restore tissue 
integrity (DeBerge et al., 2017b).
The efficient clearance of AC from tissues requires that AC are 
specifically recognized and destroyed, either by neighboring cells 
or by specialized phagocytes (Fond and Ravichandran, 2016). 
Although AC retain plasma membrane integrity, alterations in 
composition of the membrane lipids, carbohydrates, and proteins 
provide molecular cues that mark them for recognition by 
other cells. In particular, translocation of anionic phospholipids 
[phosphatidylserine (PtdSer) and phosphatidylethanolamine] 
from the inner leaflet to the outer leaflet of the plasma membrane 
represents one of the hallmarks of apoptosis (Segawa and Nagata, 
2015). Exposure of PtdSer on the outer leaflet of the plasma 
membrane can be detected directly via specific PtdSer receptors (see 
below). Alternatively, binding of proteins that act to “opsonize” the 
AC membrane enables indirect engagement of additional receptor 
pathways for the recognition and internalization of AC (Stitt et al., 
1995; Païdassi et al., 2008). Additional changes in glycosylation 
(Hart et al., 2000; Franz et al., 2006), crosslinking (Piacentini et al., 
1991), or proteolytic shedding of proteins (Dransfield et al., 1994) 
on the AC surface provide additional “apoptotic cell associated 
molecular patterns” that also influence AC recognition (Franc 
et al., 1999). The repertoire of phagocyte receptors that are engaged 
during recognition and subsequent internalization of AC may 
determine the subsequent response of the phagocytic cell.
MOLECULAR MECHANISM OF AC 
CLEARANCE
There are many different receptor families involved in the process 
of phagocytosis of AC [extensively reviewed elsewhere (Elliott 
and Ravichandran, 2010; Freeman and Grinstein, 2014; Nagata, 
2018; Lemke, 2019), summarized in Table 1]. Genetic deletion 
of a single receptor pathway seldom eliminates phagocytic 
clearance capacity, suggesting a level of functional redundancy 
in AC clearance, both in vitro and in vivo. AC clearance pathways 
may have multiple, partially overlapping physiological roles, as 
the extent to which specific deletion impacts upon homeostasis 
and immune processes in vivo differs (Gregory and Devitt, 2004). 
However, adaptation to universal gene deletion may complicate 
interpretation and studies of inducible knockouts will provide 
important additional insights into the role of specific molecular 
pathways that are involved in AC clearance in vivo.
Receptors mediating AC phagocytosis can be broadly divided 
into non-opsonic (direct recognition) or opsonic receptors 
(indirect recognition). The receptors mediating AC clearance can 
be further categorized based on their potential for transducing 
signals that control the internalization of AC (Barth et al., 2017). 
For example, although T cell immunoglobulin and mucin domain 
containing 4 (TIM4) and brain-specific angiogenesis inhibitor 1 
(BAI-1) are both capable of mediating recognition of PtdSer, only 
BAI-1 is capable of directly mediating signal transduction (Park 
et al., 2007; Park et al., 2009). For a single phagocyte, efficient 
phagocytosis may require cooperative activity of receptors 
involved in AC clearance. Optimal phagocytic responses may 
require the establishment of a phagocytic synapse with spatial 
co-localization of molecules of similar dimensions at the 
interface between phagocyte and target, together with exclusion 
of phosphatases such as CD45 or CD148 (Barth et al., 2017).
REGULATION OF APOPTOTIC CELL 
CLEARANCE
Phagocytosis of AC may be regulated rapidly (within minutes) in 
response to exogenous or microenvironmental signals via changes 
in the ligand binding activity of receptors. Alternatively, the spatial 
distribution of receptors that mediate AC uptake may result in the 
formation of receptor micro-clusters that facilitate phagocytosis, as 
has been demonstrated for FcgR (Lopes et al., 2017). Phagocytosis 
of AC may also be controlled over a more prolonged time frame 
via changes in the repertoire of receptors that are expressed on the 
phagocyte membrane. For receptors that recognize AC indirectly 
through “bridging” ligands that bind to the AC, the availability 
of those ligands represents another level of control. Increased AC 
TABLE 1 | Summary of key molecular pathways mediating apoptotic cell 
phagocytosis. Examples of molecules mediating either direct or indirect (via 
bridging molecules) recognition of apoptotic cells, together with putative signaling 
mechanisms that are triggered (Savill et al., 1990; Savill et al., 1992; Stitt et al., 
1995; Mevorach et al., 1998; Taylor et al., 2000; Albert et al., 2000; Scott et al., 
2001; Stuart et al., 2007; Park et al., 2007; Rothlin et al., 2007; Park et al., 2008; 
Tibrewal et al., 2008; Païdassi et al., 2008; Park et al., 2009; Nakahashi-Oda 
et al., 2012; Ramirez-Ortiz et al., 2013; Kourtzelis et al., 2019).
Receptor Ligand Signaling
Direct recognition
BAI-1 PtdSer GPCR – DOCK180, 
ELMO, Rac-1 (Park 
et al., 2007)
TIM-4 PtdSer Indirect via integrins 
(Park et al., 2009)
CD300 PtdSer ITIM (Nakahashi-Oda 
et al., 2012)
Stabilin-2/MEGF-10 PtdSer via GULP (Park et al., 
2008)
Indirect recognition
MER PROS1, GAS6 (Stitt 
et al., 1995)
Autophosphorylation, 
Akt, PLCγ2, FAK, Rac-1 
(Tibrewal et al., 2008)
AXL Gas6 IFNAR, STAT1, SOCS1/3 
(Rothlin et al., 2007)
SCARF (Ramirez-Ortiz 
et al., 2013)
C1q (Païdassi et al., 
2008)





FAK, DOCK180, Rac-1 
(Akakura et al., 2004; 




CRKII, DOCK180, Rac-1 
(Hanayama et al., 2002; 
Savill et al., 1990; Savill 
et al., 1992)
CD36 TSP-1 Fyn, Pyk2 (Stuart et al., 
2007)
(Savill et al., 1990; Savill et al., 1992; Stitt et al., 1995; Mevorach et al., 1998; Albert 
et al., 2000; Hanayama et al., 2002; Akakura et al., 2004; Park et al., 2007; Rothlin 
et al., 2007; Stuart et al., 2007; Païdassi et al., 2008; Park et al., 2008; Tibrewal 
et al., 2008; Park et al., 2009; Nakahashi-Oda et al., 2012; Ramirez-Ortiz et al., 2013)
Regulation of Apoptotic Cell ClearanceArienti et al.
3 August 2019 | Volume 10 | Article 891Frontiers in Pharmacology | www.frontiersin.org
phagocytosis has been shown to occur following crosslinking of 
CD44 (Hart et al., 2012) or in the presence of soluble mediators 
such as galectin-3 (Caberoy et al., 2012); here we consider some of 
the key factors that exert control of AC phagocytosis and whether 
the underlying mechanisms of regulation could be exploited for 
therapeutic gain (summarized in Table 2). 
LIPID-DERIVED MEDIATORS
Multiple studies have demonstrated the contribution of lipid 
mediators to the control of phagocytosis, shown schematically in 
Figure 1. The lipoxin family of lipids, derived from arachidonic 
acid, were shown to have anti-inflammatory effects that impact 
on the resolution phase of inflammation. Lipoxin A4 (LXA4) 
stimulates phagocytosis of AC (Godson et al., 2000), acting 
via the G-protein coupled receptor (GPCR) formyl peptide 
receptor 2 (FPR2) to induce Rho, Rac, cdc42-dependent actin-
cytoskeleton rearrangements (Maderna et al., 2010). Both 
FPR1 and FPR2 confer recognition of N-formylated peptides 
generated during bacterial and mitochondrial protein synthesis 
and are abundantly expressed on leukocytes. Although FPR1 
signaling activates pro-inflammatory signaling (Dorward et al., 
2015), certain FPR2 agonists elicit anti-inflammatory responses 
in innate immune cells (e.g., LXA4, Annexin A1, Ac2-26) 
(Scannell et al., 2007; Filep, 2013), suggesting a specific role 
for FPR2 in controlling phagocyte responses during resolution 
of inflammation. Interestingly, in a mouse model of arthritis, 
genetic deletion of FPR2 abrogated the pro-resolving effects of 
RvD3 (Arnardottir et al., 2016).
The resolvin family of anti-inflammatory/pro-resolution 
lipids derived mainly from omega-3 fatty acids, especially 
eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), includes the E-series of the anti-inflammatory lipid 
mediators, resolvin-E1 (RvE1) and resolvin-E2 (RvE2) (Kohli 
and Levy, 2009), and the D-series resolvins (Gilroy et al., 2004). 
These mediators actively promote resolution of inflammation 
via a number of mechanisms, including down-regulation of 
NF-κB signaling and dampening the effects of pro-inflammatory 
mediators (Arita et al., 2007). Resolvins also promote 
phagocytosis by binding to various GPCRs. RvE1 binding to 
ChemR23 on macrophages enhances macrophage phagocytosis 
of zymosan particles via a mechanism involving enhanced Akt 
and ribosomal protein S6 phosphorylation (Ohira et al., 2010; 
Laguna-Fernandez et al., 2018).These effects are similar to the 
rapid increase in phagocytosis of AC and zymosan particles 
that is induced by the natural peptide ligands for ChemR23 
such as chemerin (Cash et al., 2010). Similarly, RvE2 has also 
been reported to promote phagocytosis of zymosan, though 
it may act through a different repertoire of GPCR from RvE1 
(Oh et al., 2012).
The resolvin D-series (RvD1-5) lipids have also been 
demonstrated to have anti-inflammatory effects on leukocyte 
recruitment and production of anti-inflammatory cytokines, 
including IL-10. RvD lipids also act to increase phagocytosis 
via the action of different GPCR (Pirault and Bäck, 2018). RvD3 
and RvD1 act via GPR32 to increase macrophage phagocytosis 
of AC and zymosan. RvD1 also promotes phagocytosis via the 
FPR2 (Krishnamoorthy et al., 2012), which had been shown 
to regulate AC clearance by lipoxin A4 (Maderna et al., 2010). 
Macrophage phagocytosis of zymosan, E. coli (Spite et al., 2009), 
and AC was increased by RvD2 both in vitro and in vivo (Chiang 
et al., 2015). Analysis of downstream signaling suggested a 
mechanism in which RvD2 acted on GPR18 to regulate PKA 
and STAT3 (Fredman and Serhan, 2011; Dalli et al., 2013a; 
Chiang et al., 2017).
Another class of specialized pro-resolving lipid-derived 
mediators that also modulate macrophage phagocytosis 
of AC are the maresins (Serhan et al., 2009). In addition 
to increasing macrophage phagocytosis of AC in a similar 
manner to RvD1, maresin 1 (MaR1) was also shown to reduce 
neutrophil infiltration and to promote tissue regeneration as 
well as inhibiting leukotriene A4 hydrolase (LTA4H) activity, 
shifting macrophages toward a pro-resolution phenotype 
(Dalli et al., 2013c).
In summary, the activity of specialized pro-resolving lipid-
derived mediators (SPM) activity peaks during the resolution 
phase of inflammation. High affinity interactions between 
TABLE 2 | Summary of key mechanisms by which apoptotic cell phagocytosis 
is regulated. Examples of mediators that act to regulate phagocytosis of 
apoptotic cells, including putative mechanisms that are involved in regulation.
Regulatory pathway Mechanism
LipoxinA4 FPR mediated activation of myosin IIa, Rho, Rac-1, 
cdc42 (Reville et al., 2006; Maderna et al., 2010)
Resolvin E1 (RvE1) ERV-1/ChemR23 (Akt and ribosomal S6 protein 
phosphorylation) (Pirault and Bäck, 2018; Ohira 
et al., 2010), *BLT1 sequestration (Arita et al., 2007)
D series Resolvins (D1, 
D2, D3, D5)
GPR32, GPR18 (PKA, STAT3), ALX/FPR2 (Pirault 
and Bäck, 2018; Krishnamoorthy et al., 2010)
Maresin 1 (MaR1) *Inhibition of LTAH4 (Dalli et al., 2013)
Del-1 RGD-dependent binding to integrins (Kourtzelis 
et al., 2019)
Osteopontin Competition for integrin ligand binding (Sakamoto 
et al., 2016)
Fibronectin Scaffold for TIM-4 (Lee et al., 2018), β1 integrin-
dependent signaling (McCutcheon et al., 1998)
Fibronectin and CD31 Activation of integrin α5β1 and FN-dependent uptake 
(Vernon-Wilson et al., 2006)
Glucocorticoids Upregulation of MER expression and activation 
(McColl et al., 2009; Zagórska et al., 2014)
Glucocorticoids Cytoskeletal regulation (Rac-1) (Giles et al., 2001)
LXR agonists Upregulation of phagocytic receptors inc. Mer 
(A-Gonzalez et al., 2009)
CD44 cross-link Cytoskeletal regulation (Hart et al., 2012), Membrane 
picket formation (Freeman et al., 2018)
CD14 cross-link Mer phosphorylation (Zizzo and Cohen, 2018)
Galectin-3 Cytoskeletal regulation (Erriah et al., 2019)
CD47 SIRPα–ITIM mediated SHP1 and SHP2 activation 
(Barclay and Van den Berg, 2014; Okazawa et al., 
2005)
*Additional anti-inflammatory effects (Hart et al., 1997; McCutcheon et al., 1998; 
Godson et al., 2000; Giles et al., 2001; Okazawa et al., 2005; Reville et al., 2006; 
Vernon-Wilson et al., 2006; A-Gonzalez et al., 2009; McColl et al., 2009; Ohira et al., 
2010; Hart et al., 2012; Krishnamoorthy et al., 2012; Zizzo et al., 2012; Barclay and 
Van den Berg, 2014; Zagórska et al., 2014; Sakamoto et al., 2016; Freeman et al., 
2018; Laguna-Fernandez et al., 2018; Lee et al., 2018; Pirault and Bäck, 2018; Zizzo 
and Cohen, 2018; Erriah et al., 2019; Kourtzelis et al., 2019).
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different SPM and their receptors (e.g., RVD1/3-ALX/FPR2) 
suggest that there may be synergistic activity of SPM during 
the resolution phase of inflammation. In terms of regulation 
of phagocytic function, specific SPM-receptor interactions 
lead to the phosphorylation of proteins that are involved 
in the regulation of cytoskeletal organization that are also 
required for cell migration. As a consequence, neutrophil 
transmigration was reduced following treatment with SPM 
(e.g., RvD1, MaR1) together with increased evidence of tissue 
regeneration. In addition, inhibition of the pro-inflammatory 
effects of LTB4 mediated by the LTB4 receptor, BLT1, was 
induced by RvE1 and MaR1. Thus, the effects of pro-resolving 
lipid mediators are not restricted to phagocytosis of AC, in 
keeping with a broader role during resolution of inflammation 
and restoration of tissue homeostasis.
EXTRACELLULAR MATRIX—INTEGRINS 
AND THEIR LIGANDS
A role for integrin αVβ3 in AC clearance by macrophages was 
first demonstrated in 1990 (Savill et al., 1990), and induction 
of expression of αV (Andreesen et al., 1990) and partnering β 
subunits [β3 (Savill et al., 1990) and β8 (Kumawat et al., 2018)] 
during in vitro macrophage differentiation confers the capacity 
for uptake of AC via bridging factors such as thrombospondin-1 
or MFG-E8 (Akakura et al., 2004). Another αV ligand that 
promotes phagocytosis of AC and acquisition of a pro-resolving 
macrophage phenotype is Del-1, an RGD-containing secreted 
molecule (Kourtzelis et al., 2019) that binds to AC (Hanayama 
et al., 2002). Deletion of Del-1 results in reduced expression 
of many genes associated with regulation of inflammation 
including liver X receptor (LXR), TGF-β1, ATP-binding cassette 
transporter 1 (ABCA1), transglutaminase 2, Axl, CD36, and 
uncoupling protein 2. Integrin-dependent phagocytosis of AC 
can be inhibited by addition of soluble αVβ3 ligands (fibronectin 
or vitronectin) (Savill et al., 1990), or direct competitors of αV 
ligand binding such as HMBG1 (Friggeri et al., 2010). Molecules 
that bind directly to αVβ5 such as histone H3 also inhibited AC 
phagocytosis (Friggeri et al., 2012).
However, rapid regulation of integrin-dependent cellular 
interactions may also occur as a result of outside-in signaling 
(Hogg et al., 1993). Integrin-dependent signaling also regulates 
AC phagocytosis. For example, osteopontin acts to block αV/
FIGURE 1 | Schematic representation of mechanisms promoting macrophage phagocytosis of AC by lipid mediators. In addition to a role in recognition of 
N-formylated peptides that are generated during bacterial and mitochondrial protein synthesis, the formyl peptide receptor 2 (ALX/FPR2) also binds to Lipoxin 
A4, Annexin A1, and Ac2-26 (N-terminal part of Annexin A1) to increase macrophage phagocytosis of AC (Godson et al., 2000; Maderna et al., 2002; Scannell 
et al., 2007; Maderna et al., 2010). Signaling following ALX/FPR2 binding by these ligands was shown to induce rearrangements in the actin cytoskeleton in a 
Rho, Rac, and cdc42-dependent manner. GPR32 is thought to be the main receptor for the resolvin D family members 1, 3, and 5 (RvD1,3,5) that acts to promote 
phagocytosis of AC and reduce NF-κB activity. RvD1 and RvD3 were also found to bind ALX/FPR2 with high affinity and induce macrophage phagocytosis 
(Arita et al., 2007; Krishnamoorthy et al., 2010, Krishnamoorthy et al., 2012; Dalli et al., 2013b). The resolving E family member 1 (RvE1) increased macrophage 
phagocytosis of AC via binding to ERV-1/ChemR23. Phosphorylation of Akt and S6 proteins induced cytoskeletal rearrangements as well as promotion of 
transcription of the anti-inflammatory cytokine IL-10 (Laguna-Fernandez et al., 2018). RvE1 can also competitively bind to the leukotriene B4 receptor BLT4, acting 
to reduce pro-inflammatory signaling (Arita et al., 2007; Ohira et al., 2010; Laguna-Fernandez et al., 2018). Resolvin D2 (RvD2) mediated activation of GPR18 
induced an M2-like macrophage phenotype exhibiting increased phagocytosis via a mechanism involving phosphorylation of the ERK, PKA, and STAT3 (Fredman 
and Serhan, 2011; Dalli et al., 2013b). Although resolving E2 (RvE2) was also reported to induce macrophage phagocytosis, the pathway that controls this effect 
has not been clearly identified (Oh et al., 2012).
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MFG-E8-mediated engulfment via prevention of dissolution of 
the actin cup that is formed beneath bound apoptotic targets, 
thereby prolonging diffuse Rac activation (Sakamoto et al., 2016). 
Inhibition of integrin-dependent Rac1 or ROCK signaling was 
associated with reduced phagocytosis of ACs and fibronectin-
coated beads in mice lacking α8 integrins, with delayed healing in 
a model of glomerulonephritis (Marek et al., 2018). Association of 
TIM4 with αVβ3 acts to potentiate AC phagocytosis. Fibronectin 
was identified as a TIM-4 binding partner, providing a scaffold to 
bring TIM-4 and integrins together to facilitate phagocytosis (Lee 
et al., 2018). Consequently, disruption of TIM-4 interaction with 
fibronectin causes a reduction in TIM-4-dependent phagocytosis, 
possibly as a result of altered integrin signaling (Flannagan et al., 
2014). Albert and colleagues demonstrated that aVβ5 formed a 
complex with Crk/DOCK180 and Rac, homologues of the key 
phagocytic module (Ced-2, 5 and 10) identified in C. elegans 
(Albert et al., 2000).
Other integrins may also be important regulators of AC 
phagocytosis. Increased phagocytosis of ACs was observed 
following adhesion to extracellular matrix ligands in a manner 
that was partially dependent on b1 integrin activity (McCutcheon 
et al., 1998). The extent of integrin-dependent adhesion and 
signaling may be critical, since interaction with extracellular 
matrix modified by cigarette smoke resulted in reduced AC 
clearance, possibly due to sequestration of integrins involved in 
phagocytosis or cytoskeletal regulation (Kirkham et al., 2004; 
Minematsu et al., 2011; Tran et al., 2016). Similarly, reduced 
phagocytosis and pro-inflammatory cytokine production 
were reported following exposure of macrophages to bushfire 
smoke extract (Hamon et al., 2018). Fibronectin may also have 
an important role in the selective engulfment of AC following 
CD31 ligation. Although CD31 mediates tethering of both AC 
and viable cells, CD31-dependent activation of phagocyte α5β1 
facilitated specific phagocytosis of ACs via a fibronectin bridge 
(Vernon-Wilson et al., 2006).
Integrins also have a key role in the regulation of phagocytosis 
by controlling the localization of key molecules such as the 
phosphatase, CD45 (Freeman et al., 2016). In their elegant 
studies, Freeman and colleagues showed that engagement of FcγR 
increased the lateral membrane mobility of CD45 due to loss of 
cytoskeletal constraint, yet CD45 was found to be excluded from 
the nascent phagocytic cup via an integrin-dependent barrier. The 
depletion of CD45 from the phagocytic-target interface was shown 
to facilitate phagocytosis. Thus, the formation of an integrin-
dependent diffusional barrier acted to increase the efficiency of 
phagocytosis at low levels of opsonization (Freeman et al., 2016). 
We reported that cross-linking of macrophage CD44 acted to 
rapidly augment phagocytosis of apoptotic neutrophils (Hart et 
al., 1997). Although the mechanism remains to be fully defined, 
cytoskeletal reorganization observed following CD44 cross-
linking, including Rac activation, altered podosome formation, 
and migratory capacity (Hart et al., 2012), would be consistent 
with changes in the extent of CD44-dependent restriction of 
lateral membrane receptor movement (Freeman et al., 2018).
Ligation of other macrophage receptors may also act to 
increase phagocytosis of ACs. Zizzo and Cohen demonstrated 
that antibody-induced cross-linking of CD14 promoted 
phosphorylation of Mer receptor tyrosine kinase (Mer) and 
potentiated phagocytosis of ACs (Zizzo and Cohen, 2018). 
The presence of exogenous beta galactoside binding lectin, 
galectin-3, acts to promote phagocytosis of ACs (Erriah et al., 
2019), possibly via cross-linking of the integrin αVβ3 (Jiang 
et al., 2012). Galectin-3 has also been reported to bind to Mer 
(Caberoy et al., 2012).
RECOGNITION OF PTDSER VIA TYRO3, 
AXL, AND MER RECEPTOR TYROSINE 
KINASES
Mer and the related receptor tyrosine kinases Tyro3 and Axl 
enable phagocytes to recognize PtdSer exposed on the surface 
of AC via binding to the PtdSer opsonins Protein S and Gas6 
(Lemke, 2013). Although signaling downstream of Mer promotes 
cytoskeletal rearrangements that are necessary for internalization 
(Tibrewal et al., 2008), Mer signaling also has an important 
role in the resolution of inflammation by driving production 
of specialized resolving mediators, including LxA4 and RvD1 
(Cai et al., 2016; Cai et al., 2018). Mer-deficient mice exhibit 
impaired phagocytosis of ACs contributing to development 
of allergic inflammation (Felton et al., 2018), atherosclerosis 
(Thorp et al., 2008), or autoimmune diseases (Rothlin et al., 
2015). Proteases that are likely present at sites of inflammation 
can reduce the activity of Mer. Specific cleavage of Mer from 
the phagocyte surface was demonstrated to be mediated by 
ADAM17 (Thorp et al., 2011) reduced AC phagocytosis and may 
represent a key mechanism controlling AC clearance capacity 
during progression of inflammatory responses (Lee et al., 2012; 
Cai et al., 2017). In addition, the presence of soluble Mer may 
compete for phagocyte binding to protein S or Gas6 opsonized 
AC, decreasing Mer-dependent phagocytosis as a consequence 
(Sather et al., 2007). Inhibition of proteolytic cleavage of Mer 
was shown to ameliorate LPS-induced lung injury (Lee et al., 
2012), and in animals expressing a cleavage-resistant form of 
Mer, inflammation-mediated tissue damage was reduced with 
improved resolution of inflammation (DeBerge et al., 2017a).
REGULATION OF AC PHAGOCYTOSIS BY 
GLUCOCORTICOIDS
The capacity for phagocytosis of AC is altered during 
differentiation and activation of macrophages. In particular, 
acquisition of a macrophage phenotype associated with tissue 
repair correlates with increased phagocytosis of AC. For example, 
glucocorticoids (including methylprednisolone, hydrocortisone, 
and dexamethasone) are potent drivers for the engulfment of 
AC (Liu et al., 1999; Giles et al., 2001), inducing marked changes 
in the receptor expression profile of macrophages. Over 100 
genes have been shown to be modulated by glucocorticoids 
including receptors involved in phagocytosis of ACs such as 
CD163, FPR1, and Mer (Ehrchen et al., 2007). Glucocorticoid-
mediated alterations in the macrophage phenotype also include 
inhibition of release of pro-inflammatory cytokines together 
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with anti-inflammatory cytokine production (e.g. TGFβ, IL-10 
and IL-1ra), thereby promoting tissue repair and regeneration. 
In addition, downregulation or reduced phosphorylation of key 
integrin signaling molecules such as paxillin, pyk2, and p130Cas 
(Giles et al., 2001) may limit focal adhesion formation, allowing 
integrins to participate in phagocytosis of ACs. In addition, 
glucocorticoid-induced upregulation of expression of the 
integrin ligand MFG-E8 may further contribute to augmentation 
of AC phagocytosis. Deficiency of MFG-E8 or knockdown 
with RNAi reduced the extent of AC phagocytosis following 
treatment with glucocorticoids (Lauber et al., 2013). Augmented 
AC phagocytosis following glucocorticoid treatment was 
shown to be primarily dependent on Mer and the Mer ligand, 
protein S (McColl et al., 2009; Zizzo et al., 2012). Increased 
expression of Mer following glucocorticoid treatment confers 
the capacity for tethering and subsequent phagocytosis of AC 
by macrophages (Dransfield et al., 2015). In keeping with these 
findings, increased phagocytosis of apoptotic cells following GC 
treatment was not observed in macrophages from Mer knockout 
mice (Zagórska et al., 2014). The increased protein S-dependent 
phagocytosis of AC by macrophages following glucocorticoid 
treatment was shown to be reversed by interferon-γ (Heasman 
et al., 2004). This observation may be explained by the strong 
induction of Axl in the presence of pro-inflammatory cytokines 
such as interferon-γ, leading to engagement of Axl-dependent 
phagocytosis (Zagórska et al., 2014), which, in contrast to Mer, 
is not mediated by protein S.
REGULATION OF AC PHAGOCYTOSIS BY 
OTHER NUCLEAR RECEPTORS
Activation of the nuclear receptors, LXR, and the peroxisome 
proliferator-activated receptors (PPAR) γ and δ also upregulates 
AC phagocytic capacity (A-Gonzalez and Hidalgo, 2014), 
providing a mechanism for sensing the uptake of apoptotic 
material and enhancement of the phagocytic capacity 
accordingly. Specific deletion or downregulation of LXRα/β 
(A-Gonzalez et al., 2009) and PPARδ and retinoid X receptor 
markedly reduces phagocytosis efficiency (Mukundan et al., 
2009). As described for glucocorticoids above, LXR agonists 
were found to induce expression of Mer leading to augmentation 
of phagocytosis (A-Gonzalez et al., 2009). Regulation of 
macrophage inflammatory pathways by the LXR agonist GW3965 
significantly attenuated the clinical and histological severity in a 
model of collagen-induced arthritis in mice (Park et al., 2010). 
Inflammatory mediator production within the joint and serum 
pro-inflammatory cytokine levels were inhibited, raising the 
possibility that targeting LXR may represent a therapeutic target 
to reduce the severity of joint destruction in rheumatoid arthritis.
Inhibition of PPAR-γ, using the antagonist GW9662, inhibited 
LPS-induced IL-10 production and decreased AC phagocytosis, 
in part via downregulation of the key phagocytic receptors 
CD36, transglutaminase-2, and Axl (Majai et al., 2007; Zizzo and 
Cohen, 2015). Antagonism of PPAR-γ was also found to promote 
macrophage differentiation and upregulation of Mer-dependent 
AC phagocytosis. In contrast, upregulation of Mer expression 
was blocked by the PPAR-γ agonist rosiglitazone, suggesting that 
PPAR-γ negatively controls the expansion of anti-inflammatory 
macrophages that exhibit efficient AC phagocytosis (Zizzo and 
Cohen, 2015).
PHAGOCYTE PTDSER AND ENGULFMENT
It is well established that PtdSer exposure on the AC surface 
represents a near universal cue that signals phagocyte recognition 
(Segawa and Nagata, 2015). However, transient exposure of 
PtdSer on the phagocyte membrane facilitates phagocytosis via 
alteration of the local membrane environment. Callahan and 
co-workers showed that Annexin V and the lipid binding dye 
merocyanine (that binds strongly to AC) also bound specifically 
to non-apoptotic macrophages (Callahan et al., 2000), a finding 
also confirmed in C. elegans (Mapes et al., 2012). Redistribution 
of PtdSer to outer leaflet is promoted by the ATP binding cassette 
transporter ABCA1 (Marguet et al., 1999), and ABCA1-deficient 
cells are less efficient phagocytes (Hamon et al., 2000). Uptake of 
ACs also acts to provide a positive amplification loop, inducing 
expression of ABCA1 via LXR-dependent and -independent 
pathways (Fond et al., 2015; Kiss et al., 2006) leading to further 
increase of cholesterol efflux. Lyso-PtdSer induced G2A 
receptor signaling in macrophages to enhance production of 
prostaglandin E2 (PGE2), activation of EP2 receptors, and 
adenylate cyclase resulting in cAMP elevation and Rac activation 
(Frasch et al., 2011). This effect was dynamic, with low levels of 
cAMP augmenting phagocytosis of AC, whereas high levels were 
inhibitory, in keeping with previously published work (Rossi 
et al., 1998).
EXTRACELLULAR VESICLES AND 
REGULATION OF AC PHAGOCYTOSIS
A role for extracellular vesicles (EV) in phagocyte exposure of 
PtdSer was suggested by studies in C. elegans where Ced-7, TTR-
52 (PtdSer binding protein), and Ced-1 were required (Mapes et 
al., 2012). Vesicles derived from AC (apoEV) may have multiple 
immunomodulatory effects (Lynch et al., 2017) that may be 
dependent on the specific membrane composition and vesicle 
contents, or cargo (Caruso and Poon, 2018). EV originating 
from different cellular sources may have distinct surface profiles 
that exert differential effects on macrophage function. It has 
been shown that apoEVs may facilitate AC phagocytosis by 
presentation of molecules such as ICAM-3 that specifically 
direct the recruitment of phagocytes (Torr et al., 2012). Exposure 
of PtdSer on the EV surface allows engagement of receptors 
involved in AC uptake (Mohning et al., 2018), including the 
Axl-Gas6 pathway for platelet-derived EV (Happonen et al., 
2016). Phagocytosis may be further augmented in the presence 
of apoEV, suggesting that EV exert direct regulatory effects on 
macrophage functional activity (Distler et al., 2005). It is now 
clear that EV exert control of macrophage function that may 
critically determine the course of an inflammatory response. In 
addition, the inflammatory microenvironment may critically 
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determine macrophage responses to EV. Type I interferons 
were reported to promote phagocytosis of apoEV, leading to 
acquisition of a pro-inflammatory macrophage phenotype 
(Niessen et al., 2015). Interaction of phagocytes with EV 
derived from non-activated neutrophils was shown to inhibit 
pro-inflammatory cytokine production (Eken et al., 2013), 
contrasting the potentially pathogenic effects of EV derived 
from activated neutrophils (Genschmer et al., 2019). Specific EV 
contents could further regulate reprogramming of macrophage 
behavior as found for platelet-derived EV delivery of miR126 
(Laffont et al., 2016). Finally, it has been shown that apoEV 
may acquire distinct lipid profiles by binding to specialized pro-
resolving mediators, including RvD1 (Dalli and Serhan, 2012). 
This distinct lipid profile was shown to increase macrophage 
phagocytosis in a GPCR-dependent manner, via a mechanism 
that involves production of RvD2, MaR1, PGE2, and PGF2 by 
macrophages (Dalli and Serhan, 2012).
OTHER FACTORS
In general terms, the capacity for macrophage phagocytosis of 
different particles is dependent on target size and the presence 
of opsonizing ligands, including antibodies or serum factors 
(Cannon and Swanson, 1992). Early studies suggested that for 
macrophage phagocytosis of AC, prior uptake inhibited further 
phagocytic capacity (Erwig et al., 1999) possibly as a result of 
reduced membrane availability following internalization of a 
large AC target. The source of lipids that macrophages utilized for 
uptake of multiple targets (Gagnon et al., 2002) was proposed to 
be the endoplasmic reticulum (Duclos et al., 2003), but this was 
not confirmed in subsequent detailed studies (Touret et al., 2005). 
Continued uptake of AC by phagocytes may depend on metabolic 
status. For example, reduced mitochondrial membrane potential 
was found to increase phagocytic capacity, with a pivotal role for 
the Ucp2 protein (Park et al., 2011). In Drosophila melanogaster, 
fragments of ACs were shown to enhance subsequent AC 
phagocytosis. The mechanism appeared to involve activation 
of Tailless upregulation of Draper and PS3 integrin to enhance 
phagocytic activity (Nonaka et al., 2017). It is now clear that 
phagocytosis of AC also causes intracellular changes that impact 
upon macrophage function. Macrophages taking up AC were found 
to have reduced mitochondrial length, with increased expression 
of molecules involved in regulating mitochondrial fission, such as 
Drp1 (Wang et al., 2017). In drp1−/− macrophages, early ingestion 
of ACs was found to be unaffected, but later AC phagocytosis was 
reduced compared to control. Since Drp1 inhibition also reduced 
AC phagocytosis at later timepoints, mitochondrial fission 
was suggested to enable multiple AC uptake. In the absence of 
mitochondrial fission, AC induced Ca2+ responses are impaired, 
reducing subsequent phagosome formation (Wang et al., 2017).
NEGATIVE REGULATORS
Phagocytosis of AC is critically dependent on the balance of activity 
of the Rac/Rho/cdc42 family of small GTPases. Macrophages 
actively extend actin-rich processes to “explore” their surroundings 
(Flannagan et al., 2010). There is some evidence that Rho and 
Rac may be inversely co-regulated in phagocytes. Whereas RhoA 
negatively regulates phagocytosis of AC, Rac-1 activation enables 
efficient uptake, leading to formation of phagocytic “portals” 
(Nakaya et al., 2008). These AC portals, often associated with 
lamellipodia, allow multiple targets to be internalized at the same 
site. However, constitutive Rac1 activation delays phagocytic 
cup closure and inhibits phagocytosis. Downregulation of CD47 
provides a mechanism to promote phagocytosis of ACs (Lawrence 
et al., 2009). Expression of CD47 on viable cells acts to inhibit 
phagocytosis by binding to the counter-receptor SIRPα expressed 
on the phagocyte membrane (Tsai and Discher, 2008; Lv et al., 2015). 
SIRPα-dependent activation of the tyrosine phosphatase SHP1/2 
signaling results in inhibition of Rac1 activation (Oldenborg 
et  al., 2001). This mechanism for prevention of phagocytosis of 
viable cells by negative regulators such as CD47 should represent 
an important control pathway in tissue homeostasis. However, 
mice lacking CD47 exhibit enhanced susceptibility to infection 
and reduced recruitment of granulocytes (Lindberg et al., 1996); 
no other major phenotype was noted. It appears that the CD47-
SIRPα regulatory pathway is indispensable for controlling the 
extent of self-phagocytosis in a tissue environment where pro-
inflammatory conditions drive macrophage phagocytic responses 
(Bian et al., 2016). Therapeutic targeting of the CD47 pathway 
may be particularly important in diseases where phagocytosis 
of AC has been compromised. For example, antibody-mediated 
blockade of CD47 was found to restore defective AC clearance in 
atherosclerotic lesions, resulting in reduced atherosclerotic burden 
(Kojima et al., 2016). Since elevated expression of CD47 on tumor 
cells may promote tumor growth by providing an immune escape 
mechanism, blocking the CD47 pathway may provide a strategy for 
driving phagocyte destruction of tumor cells (Matlung et al., 2017).
THERAPEUTIC IMPLICATIONS
In health, non-internalized AC are present at very low levels 
within tissues (Kerr et al., 1972) suggesting that AC clearance 
capacity is matched to the overall tissue load of AC. Following 
injury or infection, imbalances between the rates of apoptosis and 
phagocytic clearance would result in accumulation of AC within 
tissues. Although the presence of AC may be a normal feature of 
physiological responses to tissue injury, AC may eventually undergo 
secondary necrosis and contribute to perpetuation of inflammatory 
responses associated with disease. Although therapeutic strategies 
targeting the apoptotic process may be sufficient to drive resolution of 
inflammation (Cartwright et al., 2019), modulation of phagocytosis 
of AC may provide additional options for promotion of repair and 
restoration of tissue homeostasis following injury or infection. One 
potential mechanism for regulating phagocytosis of cells would be 
downregulation of “don’t eat me” signals on AC targets (Barclay and 
Van den Berg, 2014). However, given the potential for off-target 
effects, we will instead consider the potential for exploiting the 
regulatory mechanisms controlling AC phagocytosis.
First, the differentiation/activation status of macrophages 
present at inflamed sites could be altered to induce expression 
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of pro-phagocytic receptors. For example, treatment with 
glucocorticoids (McColl et al., 2007) or LXR agonists (A-Gonzalez 
et.al, 2009) would upregulate expression of receptors that are 
involved in AC clearance such as Mer (Röszer, 2017) and hence 
promote phagocytic clearance of AC. An alternative approach 
might be to exploit miRNA that specifically regulates phagocytic 
receptors. Kurowska-Stolarska et al. (2017) showed that miR-
34 acted to reduce expression of Axl, and that targeting miR-34 
reduced pro-inflammatory cytokine production and dendritic 
cell activation in mice (Kurowska-Stolarska et al., 2017). The 
availability of ligands that allow “bridging” of phagocytes to AC 
targets may be critical. For example, protein S likely represents a 
key mechanism for reprogramming macrophage maturation, with 
increased pro-inflammatory mediators (TNF) and reduced anti-
inflammatory mediators RvD1 and IL-10 in the protein S-deficient 
mice (Lumbroso et al., 2018). In terms of therapy, overexpression 
of the Mer ligands protein S and Gas-6 has been shown to reduce 
inflammation (ankle swelling, pro-inflammatory cytokine levels) 
in a collagen-induced model of arthritis in mice (van den Brand et 
al., 2013). Exogenous administration of AC bridging ligands might 
have therapeutic benefit in a range of inflammatory diseases.
Second, the action of proteases that regulate the expression of 
phagocytic receptors could be blocked. Inhibitors of ADAM-17 or 
MMP9 would be predicted to reduce proteolytic downregulation 
of Mer, LRP1, SRB-1, or CD36 shedding that is associated with 
reduced capacity for phagocytosis of AC and development of 
disease, for example in atherosclerotic lesions (DeBerge et al., 
2017b). In diabetic mice, high levels of glucose downregulated MiR-
126 leading to increased expression of ADAM9 and suppression 
of Mer-dependent phagocytosis of AC (Suresh Babu et al., 2016). 
Overexpression of miR-126 conferred rescue of phagocytic 
defects in response to environmental conditions that suppress AC 
phagocytosis, such as high glucose (Suresh Babu et al., 2016).
Third, stimulation of GPCRs mediating the effects of pro-
resolving mediators may provide a rapid mechanism for the 
regulation of phagocytosis of AC.
Finally, microvesicles with defined membrane lipids or 
protein repertoires may represent a useful mechanism for the 
modulation of macrophage function (Gregory and Pound, 2011). 
Microvesicles that express accessible PtdSer might be opsonized 
with PtdSer bridging ligands or specialized pro-resolving 
mediators, providing a combination of signals that mimics the 
AC surface. Such tailored microvesicles could be administered 
directly to sites of injury or inflammation and act to promote 
acquisition of a macrophage phenotype that is pro-resolution.
In summary, AC clearance is a key process in the control of 
tissue repair and regeneration. Strategies to overcome defective 
clearance of apoptotic material could provide new approaches to 
treating established inflammatory or autoimmune diseases.
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